
### [MONDO:0015231](http://purl.obolibrary.org/obo/MONDO_0015231)
**Label:** Bartter syndrome

**Subclasses:** [MONDO:0019524](http://purl.obolibrary.org/obo/MONDO_0019524) (infantile Bartter syndrome with sensorineural deafness), [MONDO:0011013](http://purl.obolibrary.org/obo/MONDO_0011013) (autosomal dominant hypocalcemia 1), [MONDO:0013126](http://purl.obolibrary.org/obo/MONDO_0013126) (Bartter syndrome, type 4B), 

**Corr. equiv. classes:** [OMIM:601198](http://purl.obolibrary.org/obo/OMIM_601198), [OMIM:613090](http://purl.obolibrary.org/obo/OMIM_613090), [Orphanet:89938](http://www.orpha.net/ORDO/Orphanet_89938), 

**Class expressions from DL-Learner:**

- [HP:0001563](http://purl.obolibrary.org/obo/HP_0001563) (Fetal polyuria) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0200114](http://purl.obolibrary.org/obo/HP_0200114) (Metabolic alkalosis) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012605](http://purl.obolibrary.org/obo/HP_0012605) (Hypernatriuria) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012603](http://purl.obolibrary.org/obo/HP_0012603) (Abnormal urine sodium concentration) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012600](http://purl.obolibrary.org/obo/HP_0012600) (Abnormal urine chloride concentration) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012598](http://purl.obolibrary.org/obo/HP_0012598) (Abnormal urine potassium concentration) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012591](http://purl.obolibrary.org/obo/HP_0012591) (Abnormal urinary electrolyte concentration) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012590](http://purl.obolibrary.org/obo/HP_0012590) (Abnormal urine output) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012213](http://purl.obolibrary.org/obo/HP_0012213) (Decreased glomerular filtration rate) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012212](http://purl.obolibrary.org/obo/HP_0012212) (Abnormal glomerular filtration rate) 66.67%
- [HP:0000859](http://purl.obolibrary.org/obo/HP_0000859) (Hyperaldosteronism) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 66.67%


